Healthcare Equipment and Supplies
Company Overview of Nanomix, Inc.
Nanomix, Inc., a nanotechnology company, provides analytical detection devices for rapid point of care (POC) diagnostics. The company focuses on the development of mobile diagnostic tests to enable earlier and accurate testing in hospital and pre-hospital settings. It offers Nanomix System that includes a handheld reader, and an integrated and self-contained assay cartridge with a carbon nano structures biosensor for testing at the point of patient care; and Nanomix eLab, a POC testing solution for use in emergency departments and by pre-hospital first responders to speed data availability for faster diagnosis of acute myocardial infarction. The company’s Nanomix System is also used for loca...
5980 Horton Street
Emeryville, CA 94608
Founded in 2000
Key Executives for Nanomix, Inc.
Chief Executive Officer and President
Founder and Executive Chairman
Co-Founder, Co-Chairperson of Scientific Advisory Board, Chief Scientific Officer and Director
Co-Founder, Co-Chairperson of Scientific Advisory Board and Board Advisor
Chief Financial Officer and Vice President of Finance
Compensation as of Fiscal Year 2015.
Nanomix, Inc. Key Developments
Nanomix, Inc. Appoints Tom Richards as Senior Advisor
Nov 17 14
Nanomix, Inc. announced the appointment of Dr. Tom Richards as a Senior Advisor. Dr. Richards brings a wealth of healthcare and financial executive experience to Nanomix as the company drives towards the commercial launch of its first product. Prior to joining Nanomix as Senior Advisor, Dr. Richards was President and CEO of TessArae. He has previously served as an academic physician on the clinical faculty of Stanford University and most recently as an Assistant Professor of Emergency Medicine at UCSF.
Nanomix, Inc. Appoints Brian Jung as Vice President of Finance and Chief Financial Officer
Jun 30 14
Nanomix, Inc. announced the appointment of Brian Jung as Vice President of Finance and Chief Financial Officer. Mr. Jung brings significant financial and executive experience to Nanmix, having served in CFO and executive roles for several healthcare and life science companies.
Nanomix Inc. Closes Private Financing for Approximately $12 Million
Jan 30 14
Nanomix Inc. announced that is has closed private financing for approximately $12 million. The financing, received from a strategic corporate partner and existing investors, will fund the completion of development, registration clinical trials, and commercial launch of the company's mobile diagnostic platform and initial assays.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries